HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MR-guided percutaneous ethanol ablation of hepatocellular carcinomas before liver transplantation.

Abstract
It was the objective of this study to evaluate MR-guided, percutaneous ethanol injection of hepatocellular carcinoma in ten patients scheduled for liver transplantation. Using a 0.2 T open MR scanner (Magnetom Open, Siemens Medical Systems, Erlangen, Germany) and percutaneous instillation of ethanol, 12 liver tumors (median tumor volume, 6.3; range, 0.6-43.2 ccm) were treated. Coagulation necrosis, morbidity, and post-transplant histology were assessed. No major complications were observed. A mean of 16.4+/-11.4 ml ethanol was injected for each tumor. The median volume of the ablation necrosis was 12.3 (range, 0.3-48.3) ccm. Three tumors were retreated and complete radiological necrosis before liver transplantation was found in eight of 12 tumors (67%). One patient developed multifocal disease and was excluded from transplantation; thus nine of ten patients underwent liver transplantation within 3.9+/-3.1 months. In the explants, satellite nodules (n = 2), new liver tumors (n = 2) and a complete necrosis were found in five of 12 treated tumors (42%). During follow-up (median 41.3; range, 0.4-86.1 months), three patients died, but no tumor-seeding or post-transplantation recurrence occurred. MR-guided ethanol injection is feasible, and may delay tumor progression. However, the local recurrence rate is high, and the spatial resolution of a low-field MR scanner limits the detection of small tumors.
AuthorsMelanie Blum, Christian Mueller, Markus Peck-Radosavljevic, Friedrich Wrba, Gabriela Berlakovich, Ferdinand Mühlbacher, Rudolf Steiniger, Maria Speiser, Mario Pones, Michael Hüpfl, Johannes Lammer, Joachim Kettenbach
JournalMinimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy (Minim Invasive Ther Allied Technol) Vol. 16 Issue 4 Pg. 230-40 ( 2007) ISSN: 1364-5706 [Print] England
PMID17763097 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Ethanol
Topics
  • Administration, Cutaneous
  • Adult
  • Carcinoma, Hepatocellular (complications, mortality, therapy)
  • Combined Modality Therapy
  • Ethanol (administration & dosage, therapeutic use)
  • Female
  • Humans
  • Liver Cirrhosis (complications, therapy)
  • Liver Neoplasms (complications, mortality, therapy)
  • Liver Transplantation
  • Magnetic Resonance Imaging, Interventional
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: